AbbVie Inc. (NYSE: ABBV) is a large market cap stock with a market cap of 100062.72. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 18.55, a forward P/E of 11.03 and EPS of 3.34. At a stock price of 61.92 (-1.26%) it has a dividend yield of 3.68%.
EPS growth for the last five years have been 3.50%, more recently this last year it has grown by 185.20%. The next year growth is going to be about 17.87% and more long-term 16.39% after five years. EPS growth quarter over quarter is 31.10%. Sales growth for the past five years have been 7.90% and sales growth quarter over quarter is 18.20%.
For performance, AbbVie Inc. the past week has seen a gain of 5.52%. For the last month performance for AbbVie Inc. is -4.74%. While the last quarter is 6.79% and half year, 9.65%. Finally for the year, performance is -5.85%.
The 52-week high for AbbVie Inc., is at -10.96%, and for the 52-week low it comes to a value of 38.99%. The 20-day simple moving average is 0.80% and 7.86% for the 200-day simple moving average.
Volatility for the week is at 1.97%, and for the month it is 1.99%. AbbVie Inc., has a target price of 70.
In terms of debt, long term debt/equity is 6.35, and for total debt/equity AbbVie Inc. has 6.87. The gross margin is 79.80%, while operating margin is 34.20%, the profit margin is 23.00%. The current ratio is 1.6 and the quick ratio is 1.4.
Insider ownership is at 0.10%, with instituitional ownership at 71.00%. AbbVie Inc. has a payout ratio of 64.30%. With the total shares outstanding coming to 1616. The shares float is 1599.58, with the float short at 4.89%, with short ratio coming to 9.06.
In terms of returns, the return on assets see AbbVie Inc., get 10.20%, with its returns on investment at 16.90%. Return on equity is 115.60%. So will the investors see the target price of 70, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.